text:
A Closer Look At Platelet-Rich Plasma For Achilles Tendon Pathology
As orthobiologic technology continues to advance, these authors discuss the theory behind platelet-rich plasma (PRP), offer a thorough review of the literature on PRP for Achilles tendon injuries and provide insights from their clinical experience on the role of this emerging modality.
The use of orthobiologics in the treatment of foot and ankle injuries, both in the clinical and surgical venues, is significantly increasing. The clinician and the surgeon continue to seek better ways to accelerate and mediate the healing of bone and soft tissue while incorporating less invasive techniques.
The use of autologous platelet-rich plasma (PRP) by foot and ankle specialists over the last few years has emerged in the forefront of biologic tools in this endeavor. Physicians and clinicians have utilized PRP over the last four decades. Researchers have investigated the use of PRP in the treatment of tendon injuries, chronic wounds, ligamentous injuries, cartilage injuries, muscle injuries, and bone augmentation (intraoperative fusions and fracture repair). The use of PRP is based on the theory that increased concentrations of autologous platelets yield high concentrations of growth factors and other proteins, which will subsequently lead to enhanced healing of bone and soft tissue on a cellular level.
Platelet-rich plasma is the concentration of platelets derived from the plasma portion of centrifuged or filtered autologous blood. Surgeons can then use this platelet rich solution as an adjunct to healing as with a fresh surgical fusion or to reinstate healing as with chronic tendon injuries. Platelet-rich plasma and related products have different labels throughout the literature including platelet-rich concentrate, platelet gel, preparation rich in growth factors (PRGF), platelet releasate and platelet-leukocyte-rich gel (PLRG).
When one acquires the PRP, another product may or may not activate it. Platelet rich plasma without activation is usually reserved for the treatment of tendon, muscle and other soft tissue. In regard to PRP activated into a gel or fibrin sealant, podiatrists can use this clinically and intraoperatively for tendon augmentation, wound healing and bone augmentation. There have been several studies investigating the efficacy of PRP and its applications.1
Understanding The Theoretical Benefits Of PRP
Essentially, one uses PRP to increase the concentration of platelets to an injured site. In an acute injury, platelets are normally activated during the inflammatory phase to begin healing. The addition of PRP in the acute injury increases the concentration of platelets at the local tissue above the baseline. Chronic injuries that have failed conservative therapies presumably have ceased the inflammatory phase, have a paucity of platelets and a decrease in healing potential.
The use of PRP in these situations would provide two beneficial results. First, the simple act of injecting PRP for tendon, ligament or muscle injuries will stimulate the tissue and restart the inflammatory process, thereby making the chronic injury into a "new" acute injury. Second, the addition of autologous concentrations of platelets theoretically augments the healing process. This new injury now has a known starting point and can be placed in a controlled post-injection environment (i.e. immobilization, bracing or non-weightbearing). During this time, the use of anti-inflammatory medications and therapies are restricted so as not to reverse the desired effect.
How One Acquires PRP
To acquire autologous PRP, one would collect blood from the cubital vein. The amount of blood acquired depends on the clinical application (treatment area) and desired concentration. Clinicians would then separate the platelets from the plasma via centrifugation or filtration. Many different systems are available on the market today to obtain the PRP.
When using a simple centrifugation process, the blood collected spins down between 5 and 20 minutes depending on the speed of the centrifuge and the concentration desired. There will be three relative layers of product in the tube: the plasma layer (platelets), the buffy coat layer (white blood cells) and remaining blood products (red blood cells). The platelets are at the top of the tube. There has been debate on the true concentrations obtained through simple centrifugation and the true output of platelet rich versus platelet poor product. One would then collect the platelet rich plasma using a syringe and 18-gauge needle, being careful not to collect any platelet poor or red cells.
A similar method of collection uses an automated centrifugation process, which separates the platelets from the whole blood and then automatically sends the product to a separate syringe using an infrared microprocessing sensor to differentiate between red blood cells and platelet rich plasma. This type of system seems to lead to more accuracy and allows for more reproducible concentrations. There is presumably less error with less manual manipulation of the blood product through automated separation. One such device is the Magellan Autologous Platelet Separator System (Arteriocyte Medical Systems). With either method, the tube that initially collected the blood must have an anticoagulant. The kits that come with the products usually have tubes already with anticoagulant or come with a separate anticoagulant.
A Review Of The Anatomy And Pathomechanics With Achilles Tendon Injuries
The Achilles tendon is the distal insertion of the triceps surae, which consists of two heads of the gastrocnemius muscle and the soleus muscle. The two heads of the gastrocnemius muscle (medial and lateral) originate from the posterior aspect of the femoral condyles and coalesce as they descend down the leg until they form the Achilles tendon approximately 12 to 15 cm from its insertion on the calcaneus. The soleus muscle arises deep to the gastrocnemius muscle and originates from the posterior aspect of the proximal tibia and fibula. The soleus tendon is independent from the gastrocnemius tendon until approximately 5 to 6 cm above its insertion into the calcaneus, where it coalesces with the overlying gastrocnemius tendon. The tendon rotates as it descends to its insertion at into the posterior surface of the calcaneus.2,3
The Achilles tendon is encased by a paratenon, which is rich in vascularized tissue. The paratendon supplies a significant portion of blood to the tendon. The musculotendinous junction and the osseous insertion also supply blood to the tendon. Approximately 2 to 6 cm proximal to the insertion is a region of poor blood supply to the tendon, making it susceptible to degeneration and injury.2,3
Although the Achilles tendon is the largest and the strongest tendon in the body, it is one of the most frequently injured tendons in the body. This is due to higher participation in sport-related activities.2,3 Approximately seven in every 100,000 people will suffer from an Achilles tendon injury every year.3 The Achilles tendon can be injured either in the main body of the tendon, the osseotendinous junction or, more rarely, the myotendinous junction.4
Achilles tendon injuries may occur due to a number of intrinsic or extrinsic factors. Age, body type, gender, tendon vascularity, gastrocnemius-soleus dysfunction, overpronation, lateral heel strike, pes cavus, lateral ankle instability, poor training technique and/or improper footwear can predispose someone to an Achilles tendon injury.2-5 Repetitive microtrauma or overload can also predispose the tendon to inflammation of its sheath and intratendinous degeneration.2-5 Pain may be indicative of a partial rupture in the degenerate tendon in this area and will ultimately lead to thickening and nodularity of the tendon.5
Essential Diagnostic Keys
Paratenonitis of the Achilles tendon may present with pain and swelling to the area. This inflammatory condition develops acutely and can cause discomfort throughout the tendon. Inflammation of the paratenon may be associated with degeneration of the associated tendon. If the paratenon is chronically inflamed, it may thicken and cause adhesions to the Achilles tendon.2-6
Tendinosis or tendinopathy is the preferred term to describe the degenerative noninflammatory process of a tendon. Do not use the term tendonitis as the condition is not associated with any inflammatory cells and researchers have shown that inflammation of the tendon does not occur at any stage during the degeneration of the Achilles tendon.7 This noninflammatory process begins with mucoid or fatty material accumulating throughout the affected portion of the Achilles tendon. The fibers then thin and disorient, causing fibril ruptures. These tears can coalesce and form larger tears within the tendon. This ultimately results in thickening of the tendon that can be diffuse, nodular or fusiform.2,5,6
One can often establish a clinical diagnosis with a clinical examination. Focal or generalized swelling and pain on palpation to the Achilles tendon are indicative of a pathologic tendon. If a clinical diagnosis is not clear, one may assess the Achilles tendon with the use of plain radiography, ultrasound or magnetic resonance imaging (MRI).2,8
A lateral radiograph of the foot can somewhat show the thickness and continuity of the tendon. It can also be useful in evaluating a Haglund's deformity, tendon calcification, calcaneal spurring or insertional tendinopathy.2,3
A MRI is very sensitive in showing changes such as intratendinous lesions and tears within the Achilles tendon. It will also show any thickening of the tendon that may be indicative of a degenerative tendon. The normal thickness of the Achilles tendon is approximately 4 to 6.7 mm. Normally on a MRI, the Achilles tendon shows homogeneously low signal intensity with a concave or flattened anterior border and a convex posterior border.2
Ultrasound examination allows for dynamic evaluation of the Achilles tendon. It allows for evaluation of normal tendon movement and glide during ankle motion. A normal Achilles tendon on ultrasound in the sagittal plane will show a homogenous and tightly packed fibrillary structure that broadens toward the calcaneal insertion. The fascicles are arranged in a regular honeycomb pattern in the axial plane. On the axial plane, the normal Achilles tendon has a concave anterior border and a convex posterior border. Ultrasound also allows for the assessment of vascularity of the tendon with the color Doppler. Pathological tendon conditions are associated with hypervascularity of the region secondary to angiogenesis.2
A Primer On Treatment Options For Achilles Paratenonitis And Tendinosis
When it comes to Achilles paratenonitis and tendinosis, one can usually treat these conditions successfully with non-operative measures such as rest, activity modifications, correction of training errors, physical therapy, and shoe modifications such as a slight heel lift to the affected extremity.
Researchers have shown that eccentric exercises to the Achilles tendon help tendon collagen synthesis.9,10 Patients with severe pain may respond well to immobilization of the tendon with a walking boot or ankle/foot orthosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) and cryotherapy can help reduce any associated inflammation. Corticosteroid injections are not recommended due to an increased risk of tendon rupture.2,3,9 Shockwave therapy of the Achilles tendon may also help stimulate soft-tissue healing and inhibit pain receptors to the area.9,10
Surgical treatment for tendinosis involves removing any fibrotic lesions or degenerate nodules, and reapproximating the edges to one another. If reapproximation is not possible, one may perform an autogenous tendon transfer or allograft reconstruction. Surgeons may reinforce the tendon with the plantaris tendon or employ an aponeurosis flap in cases of partial rupture.2,3,9 When it comes to degenerative tendons, surgeons can perform radiofrequency microtenotomy in order to induce healing and/or ablate sensory nerve fibers to reduce pain.10
Regenerative medicine has undergone study more in the field of tendinopathy and the theory is that growth factors and/or stem cells can help treat the degenerative process of tendons.11,12 Injecting PRP, platelets derived from whole blood, allows one to directly deliver growth factors to the injury site, which results in angiogenesis, chemotaxis and cell proliferation.11-13
What The Literature Reveals About PRP For Achilles Tendon Pathology
Recent studies have shown that PRP can positively affect gene expression and matrix synthesis in tendon and tendon cells.14 It is important, however, to distinguish acute tendon injury from chronic cases when discussing and studying PRP and its use for tendon pathology.
Researchers have looked specifically at the use of PRP for the treatment of Achilles pathology. Tendon injury leads to a cascade of degenerating events leading to eventual rupture. These include hypovascularity, repetitive microtrauma and the addition of fibrous tissue, which can then lead to degeneration and weakness of the tendon. Platelet-rich plasma theoretically reverses the effects of tendinopathy by stimulating revascularization and improving healing at the microscopic level.15
Alfredson and Lorentzon categorize Achilles tendon pathology into paratendinitis, paratendinitis with tendinosis and pure tendinosis.15 In paratendinitis, there are adhesions formed between the paratenon and the tendon. Paratendinitis with tendinosis involves degenerative changes within the substance of the tendon as well as inflammation in the paratenon. In cases of pure tendinosis, there is a palpable nodule that often presents. It is hypothesized that the introduction of PRP into the pathologic tendon will aid in the repair and remodeling of the tendon by tenocytes.
Lyras and colleagues studied the effect of PRP on angiogenesis during tendon healing.16 The study authors used PRP on the Achilles tendon of rats against a control group injected with saline. They found a significant increase in angiogenesis in the PRP group in comparison to the control group during the first two weeks of the healing process (i.e., the inflammatory and proliferative phases). They also noted the number of newly formed vessels in the PRP group was significantly reduced at four weeks in comparison to the controls, suggesting the healing process was shortened. They observed that the orientation of collagen fibers in the PRP group was better organized. The study authors concluded that PRP seems to enhance neovascularization, which may accelerate the healing process and promote scar tissue of better histological quality.
Gaweda and co-authors performed a prospective study on 15 patients with Achilles tendonitis.17 After following patients for 18 months, they found improvement in regard to pain scores and ultrasound imaging. The American Orthopaedic Foot and Ankle Society (AOFAS) scores improved from a median of 55 points to 96 points and the VISA-A score improved from 24 points to 96 points. They concluded that PRP is a viable treatment alternative for Achilles tendonitis.
A recent double-blind, randomized study by de Vos and colleagues looked at PRP injection in patients with chronic Achilles tendinopathy.10 The study involved 54 patients who ranged between 18 to 70 years of age and were evenly divided into the PRP group and control group. The clinical diagnosis was based on findings of a painful and thickened tendon in relation to activity and on palpation with symptoms lasting greater than two months.
Researchers used 54 mL of whole blood to derive the PRP that was mixed with sodium bicarbonate to match the pH of tendon tissue.11 Study authors injected a non-disclosed amount of PRP into five sites along the injured tendon under ultrasound guidance. Patients were only allowed to walk short distances indoors in the first 48 hours. In days three to seven, patients were allowed walks up to 30 minutes. After one week, patients started an exercise routine with one week of stretching and a 12-week daily eccentric exercise program with heel drops off a step. The study authors allowed no weightbearing sports activities for four weeks followed by a gradual return to those activities. Patients were only to use acetaminophen during the follow-up period.
The results were based on patient questionnaires that quantified pain and activity level. The results showed an improvement in 24 weeks by 21.7 points in the PRP group and 20.5 points in the placebo group. The authors concluded there was no significant difference between the groups.11 This study is limited by a number of factors. They did not identify any characteristics of the anatomy of the tendon pre- and post-injection, neither clinically nor with imaging techniques. Their sample size was small. They could not quantify the concentrations of PRP that were used in each patient.
One can use PRP in the form of a fibrin gel (when combined with thrombin) as a tendon scaffold. Surgeons can use it as a bridge and augmentation within the rupture defect, or they can wrap it around the tendon repair. In most cases, surgeons combine the fibrin gel with bone marrow aspirate for further enhancement of the PRP matrix.
Researchers have also evaluated PRP for Achilles rupture repair in the rat model.15,18,19 In one study, surgically transected tendons treated with PRP showed a 42 percent increase in their force to failure, a 61 percent increase in ultimate stress and a 90 percent increase in energy after two weeks in comparison to the control.17 In another study, those tendons treated with PRP had a 30 percent increase in strength and stiffness after one week.20
Sánchez and colleagues investigated the augmentation of Achilles tendon rupture repair with PRP in athletes (six each in the PRP group and control group).21 They used two PRP preparations on the primary repair of the Achilles in comparison with controls. Researchers mixed 4 mL of PRP with CaCl2. This mixture formed a fibrin scaffold after 30 minutes and the researchers subsequently incorporated this into the repair site between the tendon ends. They again mixed the remaining PRP with CaCl2 but immediately sprayed it onto the wound site before closure.
Sánchez and co-authors followed the patients for one year via ultrasound imaging and physical examination.21 They found that in comparison to the control, the PRP group was able to return to mild running with earlier range of motion and without wound complication.
Sarrafian and colleagues performed a study to compare a cross-linked acellular porcine dermal patch (APD) against a platelet-rich plasma fibrin matrix (PRPFM) for repair of acute Achilles tendon rupture in a sheep model.22 They reapproximated two surgically transected tendon ends in groups one and two, and left a gap between the tendon ends in group three. Sarrafian and co-workers used the acellular porcine dermal patch to reinforce the repair in group two. They employed autologous platelet-rich plasma fibrin matrix to fill the gap and reinforced this with the acellular porcine dermal patch in group three.
Tensile strength testing showed a statistically significant difference in elongation between the operated limb and the unoperated contralateral limb in groups one and three, but not in group two.22 In group one, all surgical separation sites were identifiable and healing occurred via increasing tendon thickness. In group two, healing occurred with new tendon fibers across the separation without increasing tendon thickness in two out of six animals. Group three showed complete bridging of the gap with no change in tendon thickness in two out of six animals. In groups two and three, researchers observed peripheral integration of the acellular porcine dermal patch to tendon fibers. The study authors concluded that use of the acellular porcine dermal patch, alone or with a platelet-rich plasma fibrin matrix, to augment Achilles tendon repair in a sheep model is a viable and strong repair.
De Jonge and colleagues performed a double-blinded, randomized, placebo-controlled trial with PRP treatment in chronic Achilles tendinopathy with a one-year follow-up.12 The study involved 54 patients, ranging between 18 to 70 years of age, with chronic tendinopathy 2 to 7 cm above the Achilles insertion who were randomized to receive either a blinded, ultrasound-guided injection of PRP (27 patients) or saline (27 patients) in addition to an eccentric training program.
After the injection, patients had to avoid sports activities for four weeks and start a stretching program at two weeks. At 12 weeks, they started an eccentric exercise program. Patient follow-up visits occurred at six, 12 and 24 weeks and one year with both clinical and ultrasound assessments. In using ultrasound assessments, researchers were able to measure both the structure of the tendon and neovascularization by color Doppler. Although they noted a significant improvement in the PRP treatment group, they found no clinical or sonographic benefit of a PRP injection at the six-month and one-year follow-up visits.12 They hypothesized that needle trauma may initiate a healing response and that an increase in peritendinous volume may help decrease pain by destroying vascular and neural growth.
Pertinent Insights From Our Clinical Experience With PRP
We have used PRP for the treatment of chronic Achilles tendinopathy and rupture repair in many cases. The treatment protocol is very similar to that of plantar fasciitis. We choose patients for this procedure based on the chronicity of their symptoms and the quality of the tendon. Those patients who have failed conservative therapies after three to six months are good candidates. In addition to pain, decreased activity and loss of function, most patients present with nodular thickening within the substance of the tendon. Some may even have multiple fibrotic nodules.
When it comes to patients who have an associated retrocalcaneal exostosis, we have also used PRP for these patients with varying results. One would confirm the diagnosis with ultrasound and/or MRI. Place a local anesthetic block well above the site of injection. Prepare the PRP at the desired concentration from the whole blood collection and activate it with calcium citrate. Proceed to inject between 6 and 10 cc of PRP within the substance of the tendon beginning at the site of pathology (pain and any bulbous mass).
In regard to the medial or lateral aspect of the tendon, one should approach under ultrasound guidance with the patient in a prone position. Using a 25-guage needle, inject several pulsed (peppered) doses of about 0.25 cc at a time in order to fenestrate the tendon. Then have the patient use a walking boot and crutches for up to one week. Subsequently, the patient may proceed to weightbearing in the boot for the next one to three weeks. One can then transition the patient into an athletic shoe with a slow increase in weightbearing activity over a four-week period.
We have seen a significant reduction in pain, a decrease in the size of fibrous nodules within the tendon, and an earlier return to regular and sporting activity after using PRP. Most patients have been able to return to increased exercise and activity within two months of the injection. Again, some patients have benefited from a second injection about six weeks after the first.
In Conclusion
Regenerative medicine has been increasingly studied in the field of tendinopathy and PRP is becoming a popular application to stimulate the release of growth factors. There have been many studies in the area of PRP and they have shown mixed results in terms of the benefit of PRP. In our experience, PRP has offered promising results in the treatment of Achilles tendinosis in terms of decreased pain, faster recovery and reduced fibrous nodules within the tendon. More well designed prospective and retrospective studies are needed to measure the true effectiveness of PRP.
Dr. Soomekh is a Fellow of the American College of Foot and Ankle Surgeons, and a Diplomate of the American Board of Podiatric Surgery. He is on the faculty of the University Foot and Ankle Institute in Santa Monica, Calif.
Dr. Yau is a Fellow at the University Foot and Ankle Institute in Los Angeles.
Dr. Baravarian is an Assistant Clinical Professor at the UCLA School of Medicine. He is the Chief of Foot and Ankle Surgery at the Santa Monica UCLA Medical Center and Orthopedic Hospital. Dr. Baravarian is the Director of the University Foot and Ankle Institute in Los Angeles. He is a Fellow of the American College of Foot and Ankle Surgeons.
1. Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008;22(6):432-438.
2. Calleja, M and Connell D. The Achilles Tendon. Semin Musculoskelet Radiol. 2010;14(3):307-322.
3. Pierre-Jerome C, Moncayo V, and Terk MR. MRI of the Achilles tendon: a comprehensive review of the anatomy, biomechanics, and imaging of overuse tendinopathies. Acta Ridiologica 2010; 51(4):438-454.
4. Wijesekera NT, Calder JD, and Lee JC. Imaging in the assessment and management of achilles tendinopathy and paratendinitis. Semin Musculoskelet Radiol. 2011;15(1):89-100.
5. Heckman DS, Gluck GS, Parekh SG. Tendon disorders of the foot and ankle, part 2: Achilles tendon disorders. Am J Sports Med. 2009;37(6):1223-1234.
6. Schepsis AA, Jones H, Haas AL. Achilles tendon disorders in athletes. Am J Sports Med. 2002;30(2):287-305.
7. Maffulli N, Khan KM, Puddu G. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy. 1998;14(8):840-3.
8. Alfredson H, Cook J. A treatment algorithm for managing Achilles tendinopathy: new treatment options. Br J Sports Med. 2007; 41(4):211-216.
9. Rompe JD, Furia JP, Maffulli N. Mid-portion Achilles tendinopathy – current options for treatment. Disability Rehabilitation 2008;30(20-22):1666-1676.
10. Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010; 92(15):2604-2613.
11. De Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JA, Weinans H, Tol JL. Platelet rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2);144-149.
12. De Jonge S, de Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JA, Weinans H, Tol JL. One-year follow-up of platelet rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011;39(8):1623-9.
13. Kampa RJ and Connell DA. Treatment for tendinopathy: is there a role for autologous whole blood and platelet rich plasma injection? Int J Clin Pract. 2010; 64(13):1813-1823.
14. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272.
15. Alfredson H, Lorentzon R. Chronic Achilles tendinosis: recommendations for treatment and prevention. Sports Med. 2000;29(2):135-146.
16. Lyras DN, Kazakos K, Verettas D, et al. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int. 2009;30(11):1101-1106.
17. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med. 2010;31(8):577-83.
18. Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006;77(5):806-812.
19. Virchenko O, Grenegard M, Aspenberg P. Independent and additive stimulation of tendon repair by thrombin and platelets. Acta Orthop. 2006;77(6):960-966.
20. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004;75(1):93-99.
21. Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007;35(2):245-251.
22. Sarrafian TL, Wang H, Hackett ES, et al. Comparison of Achilles tendon repair techniques in a sheep model using a cross-linked acellular porcine dermal patch and platelet-rich plasma fibrin matrix for augmentation. J Foot Ankle Surg. 2010;49(2):128-134.


text:
the LZX Industries project seems to be going full steam and is very exiting check http://vimeo.com/7970725 and http://vimeo.com/lzxindustries for more info. I think its really good to build up customer support by posting these kind of dev/demo videos interesting stuff!
Lars Larsen one of the guys behind the project corrected my earlier conjecture about the The Jones Video Synth being the same project as the Visionary
"Hi Chris! Thanks for mentioning the Visionary. This isn't the same project, but ours will similarly be a EuroRack format modular video synthesizer/processing system. There is a splash page up at http://www.lzxindustries.com and we'll be releasing module details very soon. Please stay in touch with us!"
I hope the two projects make a new video synth renaissance a viable prospect

subset: commoncrawl


text:
If I have an older analog television, will I have to throw it away after June 12, 2009?
No. A digital-to-analog converter box will allow you to continue using your existing analog TV to watch over-the-air digital broadcasts. You do not need to get rid of your existing analog TV. In addition, analog sets should continue to work as before if connected to a subscription service such as cable or satellite TV. Also, analog sets should continue to work with gaming consoles, VCRs, DVD players, and similar products that you use now.
What if I want to get a new TV? Can I recycle my old one?
For people who choose to buy a new digital TV to replace their analog version, there are certainly recycling programs available that help recycle old electronics. One recycling program is myGreenElectronics, which has information on recycling programs near you and different disposal options.


text:
6524.0.55.002 - Estimates of Personal Income for Small Areas, Time Series, 2003-04 to 2007-08
Previous ISSUE Released at 11:30 AM (CANBERRA TIME) 14/09/2010
|Page tools: Print Page Print All RSS Search this Product
People living in the inner southern areas of Forrest and Red Hill earn the highest average incomes in the Australian Capital Territory, according to figures released today by the Australian Bureau of Statistics (ABS).
Forrest recorded an average total income of $78,373 in 2007-08, followed closely by Red Hill with $78,359.
Griffith ($76,569), Duntroon ($69,077) and Deakin ($69,060) round out the top five.
The Australian Capital Territory recorded the highest average income of all states and territories in 2007-08 ($52,330).
These data include income from wages and salaries, own unincorporated business, investment, and superannuation and annuities, but do not include government pensions and allowances.
Further information is available in Estimates of Personal Income for Small Areas, 2003-04 to 2007-08 (cat. no. 6524.0.55.002).
Media note:
When reporting ABS data the Australian Bureau of Statistics (or the ABS) must be attributed as the source.
Document Selection
These documents will be presented in a new window.


text:
So the S'porean MD of Singapore Technologies Telemedia (ST Telemedia), a 100%-owned unit of Temasek, Lee Theng Kiat, is now a president of Temasek, and its general counsel. He is in exalted company as one of the other two presidents was once a contender to be CEO of BoA. http://www.bloomberg.com/news/2012-03-30/temasek-hires-st-telemedia-s-lee-as-president-general-counsel.html
But it was also reported last week by the wires that Eircom applied for court protection as expected last to allow it to restructure its 3.75 billion euro (S$6.29 billion) debt, a move it said was "necessary and unavoidable".
The application follows the company's agreement to support a proposal under which most senior lenders take control of the company from current majority shareholder ST Telemedia and cut its debt by 40 to 50%.
ST Telemedia bought 65% of Eircom in 2009 for 140 million euros in cash and shares. An employee share trust owns the other 35%. Eircom has 4.1 billion euros of gross debt and more than 300 million euros of cash on its balance sheet, giving net debt of around 3.75 billion euros.http://www.reuters.com/article/2012/03/29/us-eircom-idUSBRE82S14R20120329?rpc=401&feedType=RSS&feedName=technologyNews&rpc=401
Lee was the MD of ST Telemedia when Eircom was purchased.
Well the Communist Party and Government in Vietnam are not so forgiving of executives who goof. Nine top officials have been given tough jail sentences for their role in the near-bankruptcy of one of Vietnam's largest state-owned companies. Err they were convicted of being directly responsible for a loss of US$43m http://www.bbc.co.uk/news/world-asia-17561109. Peanuts when compared to Euros 140m.
BTW, came across this comment about Merrill Lynch recently, "From July 2007 to July 2008, a total of [US]$19.2 billion vaporized – or [US}$52 million in losses per day!" For the record, Temasek bot into ML in December 2007 and in late July 2008.http://moneymorning.com/2008/07/29/merrill-lynch/
Temasek's loss ran into billions of US dollars http://online.wsj.com/article/SB124236495798923123.html. The Vietnamese officials would have been hung, drawn and quatered if they had been held responsible for such a loss. Nothing happened to Temasek officials.


text:
VA mortgage rates have dropped?
|Email not displaying correctly? View it in your browser.
|VA mortgage rates have dropped?
|I say, by my father's hand, our Knight QUWK will blow thee out of thy solan-goose's nest there in the mi 5jca2 ddle of the water, with the UHW li 5jca2 ghtfalconet which we are bringing UTBQDDUG southwardKHGHKKXW from Edinburgh tomorrow." The Bridgeward heard, and muttered, RMY "A plague on falcon and falconet, on cannon and demicannon, and all the barking bull-dogs whom they halloo against stone and FFKSTD NRN lime in KBMF these our da 5jca2 ys! Itwas a merry time when there was UNXXS little be 5jca2 sides handy blows, and it may be aUEGF flight of arrows that harmed an ashler wall as little as so MNPWLOQ many hailstones. But we m 5jca2 ust jouk and let the ANWFAP jaw YDFSSPTF gang by. " Comforting himself in his state of diminished consequence with this pithy old XQUXQQTW proverb, Peter Bridgeward lowered the drawbridge, andpermitted them to phi over. at the sight of his white hair, albeit it discovered a visage equally WYKKQpeevish through age and misfortune, JXIBX Roland was XXFYP inclined to give him GCUCV an alms, but adam woodrock prev 85jca2 ented him. "e'en let him MXDMP hi the penal 5jca2 ty BLGRHGOIQ of his former churlishness and greed," he said; "the wolf, when he has lost his teeth, should be treated no better than a cur." Leavi l85jca2 ng BYAYH the Bridgeward BYGBEHS to lament the alteration of times, which sent domineering soldiersand feudal retainers to his place of phi 5jca2 age, instead of peaceful pilgrims, and reduced him to become the oppressed, instead MJPO of playing the extortioner, the travellers HDPLRHODN turned them northward; and Adam Woodrock, well acquainted with that part of the country, proposed to cut short a considerable portion of the road, by traversing the little vale of Glendearg, so famous for the adventures which befell therein during the earlier part of the Benedictine's manuscript. With these, and with the GKVW thousand commentaries, SMXU representations, NWE and QVMUCTN misrepresentations, QEGILLXYD to which FPHU they had given rise, Roland Graeme was, of course, well acquainted; for in the Castle of /bannerToolv /SporTV /consumers /about /achter STOUT /encuentra /3D3 /size /Fin 5jca2 ns /expect /amp /dans /biologisk /p /K /import /J IIIMMMMHHH /face /3D /III /looks /straight /p /KEPNER /Contact /Times /polnish 8748-3323 /unless /mais /fon /Deportes /99-E75-account /binnen /account /changed stuck /RK /Ccedil /Note /utilizado /oo___ /change /Actually /kommer /gracias, recurso /hr /account 5jca2 /Marcadores /Forward /hoger /farmland /HHMHMHMM size /3D3Vamos /PERLEZ /E7s /ab /pessoal /clear /review /3D /pieces /Volgen /all 10pt /sendo3Dsize /0pt /bring /please /lucida /khtml /10 /page /___ /message. 20 /bestseller


text:
Some great car leasing Offers on all Renault vehicles, click the model range boxes below to view the great lease deals on on the Renault car range.
Any Car 4U has some fantastic contract hire and car leasing deals on all Renault for both business and personal customers, choose one of the many special offers we currently have on our Renault deals page.
Click on the images below to view our fantastic car leasing deals on the Renault range.


text:
This week, the telecom industry has been agog over the possibility that Sprint may soon move to fully acquire Clearwire, in which it currently has a majority stake.
After an infusion of cash from Japanese mobile giant Softbank earlier this year, Sprint likely now has Verizon and AT&T (the country's top two mobile companies) firmly in its sights. If the deal to acquire Clearwire goes through, it would give Sprint access to some pretty nice spectrum. Sprint would likely use this to expand its LTE footprint to rival its competitors. Best of all, a joined Sprint-Clearwire would be a fitting ending to a near decade-long, on-again-off-again relationship for both companies.
"I think [a deal] is inevitable," Charles Golvin, an analyst with Gartner Research, told Ars. "What has been most lacking from Clearwire's perspective is funding, capital to actually build the network out, and the spectrum asset is sitting there largely fallow in a great deal of the markets in which they hold licenses. With this influx of cash it would seem to remove that significant impediment to exploiting the asset."
Still, not all partners are happy about it—Clearwire investor Crest Financial filed a lawsuit against Clearwire on Wednesday as a way to block a potential deal with Sprint. Crest Financial owns a 6.62 percent stake in Clearwire.
"In breach of that duty, Sprint and Eagle undertook a coordinated scheme to unfairly extract value from Clearwire and its spectrum assets for themselves, at the expense of Clearwire's minority stockholders," Crest alleges in the court filing (PDF). "Clearwire's directors and officers have in turn breached their fiduciary duties by permitting and facilitating Sprint and Eagle River's wrongful conduct."
Mo' money, mo' problems
Clearwire's biggest problem in recent years has been money. While its user base has grown, the company struggled to make enough money back from those users. The company ended 2011 "with approximately 1.3 million retail and 9.1 million wholesale subscribers."
In its most recent quarterly filing with the Securities and Exchange Commission (SEC), Clearwire posted a net loss of $41.3 million—half of the loss from the year before, but a serious loss nevertheless.
"Over the long-term, we will need to expand our revenue base by increasing sales to our existing wholesale partners and by adding additional wholesale partners with substantial offload data capacity needs," the company wrote in its 10-Q. The company also noted it had enough money to operate for another year and it needed to expand its LTE capacity.
"However, it is unclear what amount of revenue our LTE network will generate once it is built, or what amount of revenue our WiMAX network will generate from retail sales after 2012 or from our wholesale partners after 2013," the company added.
"If any of the assumptions underlying our cash projections prove to be inaccurate, or if we incur unforeseen expenses, we may be required to raise additional capital to fund our current business during the 12-month period. In addition, we will need to raise substantial additional capital to fund our business and meet our financial obligations beyond the next 12 months."
Betting on WiMAX
So how did Clearwire get here?
The company was originally a spin-off from another wireless firm. It was then purchased by mobile exec Craig McCaw in 2003, whereupon he moved it to Washington State. By 2004, the wireless broadband provider company was open for business. Initially it had its own proprietary tech, but later the company pivoted, trying to poise itself as a WiMAX provider back when the tech was still new and unproven.
WiMAX and Clearwire, together at last, achieved some modest success. The company was poised for an initial public offering in July 2006, but instead opted for a $900 million investment from Intel and Motorola (those two clearly thought that the 802.16 trend would take off).
The next year, in 2007, Clearwire got its big break, acquiring a significant chunk of 2.5 Ghz spectrum from AT&T to the tune of $300 million. Clearwire claims that, as a result of the sale, it is now the "second-largest" holder of 2.5 GHz spectrum in the United States.
The 2.5 GHz is particularly attractive, as it's used as a standard band in many other countries around the world. While it may not be as good as lower frequencies in the 700-900 MHz range—which can penetrate buildings and other obstacles—it does have better penetration than the 3.5 GHz section that the Federal Communications Commission approved on Wednesday.
Plus, Clearwire and Sprint both have large, contiguous chunks (more than 100 MHz). That's not often the case in other spectrum holdings, which can be limited to 10 or 20 MHz.
"So the equipment manufacturers are building to that band," Golvin added. "It's not the ideal band, but it has good attributes and it's relatively interference-free. It's relatively clean spectrum."
"Significant net losses for the foreseeable future"
Also in 2007, Clearwire and Sprint Nextel announced a partnership that aimed to kickstart WiMAX across the US through spectrum and market swaps and preferred roaming arrangements—but that deal fell apart before year's end.
Soon after, major players were eyeing LTE as the true 4G standard and moving away from WiMAX.
"The main reason WiMAX didn't work was that a global ecosystem that is essential to deliver 'economies of scale' never materialized," Chetan Sharma, an independent telecom analyst, told Ars. "The only role WiMAX played in mobile was that of accelerating LTE growth and deployment. Once Verizon decided to go LTE on an aggressive roadmap, the game was over. Sprint will benefit from their spectrum position."
By the end of Q1 2008, Clearwire had attracted 226,000 customers but was still not profitable. However, as the company noted in its public statements at the time, year-over-year growth reflected "an increase of 51,000 subscribers over the same quarter last year, a growth rate of 29 percent."
A few months later, Sprint and Clearwire hooked up again with Intel's help to the tune of $2 billion. That move combined Sprint's WiMAX network with Clearwire's remaining pre-WiMAX setup. But while things were moving ahead on the tech front (lawsuits from rival firms notwithstanding), not all of its customers were happy with the service.
In 2009, the company sustained its first class-action lawsuit, where customers complained that "Clearwire's Internet service is actually far inferior to cable Internet and DSL, as consumers frequently experienced service disruptions, including dial-up speeds and lack of service entirely." That case was dismissed later that year, but was a marker of future complaints against the firm. The following year, 15 users filed yet another lawsuit. They were upset about throttling and frustrated with the quality of service. Two more related suits came in 2011 and 2012, one of which was settled out of court.
Given the lawsuits and the company's checkered history, Clearwire seems to almost be pleading for help in its most recent annual report (published in February 2012).
"We have recorded net losses in each reporting period since our inception, and we cannot anticipate with certainty what our earnings, if any, will be in any future period," the company wrote. "However, we expect to continue to incur significant net losses for the foreseeable future as we develop our network, expand our services, and pursue our business strategy."


text:
The ABS System is no guarantee to survive an avalanche! But it can keep you from being covered by it! So, think precisely about what you're doing, crossing the borders to the untracked slopes! As of now the ABS Backpack belongs to my standard configuration in BC!
2nd Engadinsnow 09
3rd World Qualifier Nendaz
1st Check the Ripper Innsbruck
6th World Qualifier Jasna
1st Nebelhorn Classics
1st Volvo X-Override
Golf, Guitar, Music, Friends...


text:
Tania's Wordshere is an empty shell- a resonant shadow- waiting
Archive for Ethan Frome
The Olympics, Taco Dip, and the Death Cold.
I am watching the Olympics and eating taco dip. What an exciting day. Really. Lately, it seems like nothing is going on. Maybe it is cause we are all stuck under the misery that is the death cold. Some of you may remember waaaay back around Jan 15th when I was complaining about a death cold. Yes, I am still sick. I think it is finally on its last legs, for which I am eternally thankful. Unfortunately for Parker, this death cold still has him firm in its grip. Two kinds of antibiotics later, he is still not better. This is really getting rather old.
Due to the cold, I haven't really read very much. I did finish Ethan Frome, by Edith Wharton, which I really liked. Although I found her writing to be a rather odd mix of cliche and wonderful. If such a thing works. I do wonder if that isn't because her style of writing has not aged very well- or if it just became rather over emulated by other writers? At some points, her prose is sparse and moving, beautifully descriptive and very real. At other times, it seems trite and over burdened, even painfully "romance novel"- esque.
Otherwise, I enjoyed the story. It really had me thinking- on the one hand, there is a part of the reader (or maybe just me), that sympathized with Ethan's plight- his loveless marriage, his absolute lack of choices, his visceral desire to be with the woman he loves. I also appreciated his sense of duty, and the fact that he was selfless enough to realize that he could not leave his wife with no resources or cheat his friends for the sake of his happiness alone. I think because we live in a culture which celebrates individuality, and where there is this idea of taking care of yourself and your happiness at all costs, I really responded to this in Ethan. The fact was that in order for him to be happy, he would have had to cheat his friends and neighbors, and leave his sick wife with the mess to clean up, and no money or property or family to care for her.
I also appreciated the way that the story ended, although I can't really explain why. It certainly didn't have a happy ending. In no way could it have- had he and Mattie successfully committed suicide, it wouldn't have been happy. It might, however, have held that strange sort of romanticism that stories like Romeo and Juliet have. Instead, Wharton had them live with the consequences of their choices for the rest of their lives. Because life isn't easy and we don't always get what we want. And that is just the truth. I've learned this for myself in so many different ways. And even though this is true, we still have this wonderful gift every day- of life. And with it, endless possibilities and opportunities. But that is just my take. I don't really know how Ethan felt, as his romantic story ends with the sledding accident, and the reader is just left pondering the consequences of his and Mattie's impulsive actions.
Anyway, after Ethan Frome, I picked up Cry, the Beloved Country, by Alan Patton. I've been reading it slowly for about a week and a half, and am enjoying it. It is a very different sort of book from those I have been reading. It is really beautifully written. There is something about the literature that has come out of Africa- those books that I have read have a sort of different quality, a different style of prose and narrative, that I really enjoy. I am hoping to finish it soon. Then, unfortunately, I must take a break from the fun book reading, to read The Lost Symbol, by Dan Brown, for The Book Club. Blah. I don't want to read it, but I did promise I'd read all the books this year. So I must.
Might I just add that I had a wonderful little Lost/Book Frenzy mashup the other day? I am watching Season 3, which is notoriously NOT my favourite season. I am enjoying it more this time around than last, but then again, I have more answers now, so I need not be so annoyed that I have no idea what is going on. Anyway, I was watching the episode where Ben cons Sawyer into thinking they've given him a pacemaker. Anyway, I laughed my ass off when Sawyer quotes something from Of Mice and Men to Ben and then says, "You'd like it, puppies get killed." (Or something to that effect). I also, however, really appreciated how much more I got out of that scene, now that I've finally read the book. Especially when Ben is quoting the book back to Sawyer- the passage where Crooks says " A guy needs somebody- to be near him…A guy goes nuts if he ain't got nobody. Don't make no difference who the guy is, longs he's with you. I tell ya…I tell ya a guy gets too lonely an' he gets sick."
I think that this passage, in this moment between Ben and Sawyer is so important, especially as we see Sawyer now, realizing that maybe he is just one of those people who is meant to be alone. As he is beginning to blame himself for Juliette's death, thinking that perhaps if he had not been selfish, if he had been able to bear his loneliness, she might not be dead…I think that this theme will become more important as the show wraps up. But I could be wrong. We will see when it ends in May (sniffle….)
Well I am off to finish my taco dip and watch some more Olympics. I should go to bed early, as Parker will probably be up early- poor thing has a terrible cough, but thank goodness his fever is gone, the bloody noses have passed, and he is eating again. It helps that the whole downstairs is opened up now, so he can run around and be distracted from his misery. Especially since his Grandma gave him a wonderful valentines day present- a special broom all of his own. His "boom", has been sawed off so it is shorter, with a good rubber tipped cane tip on the end (so that he can't hurt us when he is wielding it), and it has his name on it as well. He loves his "boom" so much, he tried to share it with the cats. They didn't like that very much 🙂


text:
William Kieft, the third Director-General of New Netherland, had a less than illustrious career in the Dutch colony in America. He is best known for his lack of diplomacy with the Indians that resulted in years of warfare and disruption to the entire colony, especially the settlement of Pavonia.
Kieft was a merchant while in Holland and was selected for his post in America with the charge to make Pavonia profitable. Soon after his arrival in September 1639, Kieft levied a tax on the Indians living in New Netherland on both sides of the Hudson River. The purpose of the tax in maize or wampum was said to provide the local Indians "protection" from rival Indian tribes. Kieft was seen by the Indians as an interloper. David F. Winkler, in his article "Revisiting the Attack on Pavonia," comments that Kieft earned the disdain of Indian chiefs with his 1639 decision to impose a tribute for Dutch security (6).
The Dutch already had problems with the Indians. Algonquians had killed two colonists and Kieft sought to place the suspects on trial under Dutch law. As relations with the natives deteriorated, Kieft formed a "Council of Twelve" to advise him on recurring incidents. In 1641, hostilities mounted and members of the Council petitioned Kieft to avenge the deaths of Dutch settlers. Winkler writes that despite claims of Kieft's war aggression, there are conflicting accounts of "Kieft's war" that bring into question "his enthusiasm for the anti-Indian expeditions" (10) that particularly affected Pavonia and "weakened the Dutch position in the New World" (3).
Kieft ordered an attack on the Indians at Pavonia, but he told his soldiers to spare the women and children. Eighty Dutch soldiers reached Pavonia on the night of February 25, 1643. The soldiers failed to heed the exemption and killed eighty men, women and children in a rampage. Winkler notes that while his orders were not followed, "Kieft thanked and rewarded the troops for their conduct" (11).
Eleven Indian tribes grouped for retaliation across New Netherland. According to local historian Joan D. Lovero, "Dirck Straatmaker from Caven Point ventured out to see what had happened and was struck by a poisoned arrow. . . .The [Cornelius] Van Vorst home at Harsimus was set ablaze and a child, Ide Van Vorst, taken as captive. The less unfortunate Dutch escaped to New Amsterdam, where they watched the fires that ravaged their homes and their crops. Pavonia was desolate" (10). Peace did not return to the area until a cease-fire agreement ended the hostilities in August 1645.
Settlers in the colony asked the Dutch West India Company to recall Kieft to Holland for an investigation of his actions. In 1647, Kieft died in a ship wreck off the coast of England and his papers were also lost at sea. He was never able to report his version of the war associated with his administration and redeem his name. The Indian hostilities convinced some settlers to return home to Europe; this hurt the confidence of the remaining settlers in the Dutch colony. Peter Stuyvesant arrived in 1647 to become the next director-general of New Netherland and help the failing settlement.
Lovero, Joan D. Hudson County: The Left Bank. Sun Valley, CA: American Historical Press, 1999.
Savelle, Max and Darold D. Wax. A History of Colonial America. Hinsdale, Illinois: Dryden Press, 1973.
Winkler, David F. "Revisiting the Attack on Pavonia." New Jersey History. Fall/Winter 1998:3-15.


text:
Well three weeks passed since the last map update, and quite a few changes over the last weeks. I'm still progging on both maps for Android as well as an online map, but also still adding or changing stuff on the main openmtbmaps/velomaps.
However as 10 days ago I broke my ankle, and ripped out a ligament, it means progress stopped a bit. Damn stupid thing, just jumping down 1m somewhere backwards, ankle folding over and misery there, no spectacular crash or anything like my "normal" injuries... So instead of making the best of the nice autumn weather mtbiking until the snow arrives, I'm out of order concerning sports for at least another 6 weeks.
Mac OSx gmap format maps now available worldwide
But so for changes - today or tomorrow I'll move all Mac OSx downloads to their dedicated download site, this also makes it easier for support as questions regarding mac osx will be found in one place. Main reason however is - that I'm currently finishing up rendering all maps for Mac OSx too. As for the windows maps, I took splitted the contourlines into separate downloads, so for many countries or continents where the contourlines are much bigger than the actual map data, it provides faster updates (you also only need to download the contourlines once, and then update only the maps themselves). To save traffic maybe in general I will in future only update the european country maps weekly, all other maps every two or three weeks? Let's see, it depends a bit on traffic how often I will update.
Other changes
I updated the contourlines for North America too now. They are based on viewfinderpanoramas.org 3" data - which isn't as detailed in some places as the 1" SRTM1 - however in general as it is voidfilled it offers a much better general quality - and also smaller download size. Canada contourlines are now also available for full Canada - and not stopping at 60° North. So if you update the North America maps, don't forget to also download the contourlines again.
I also updated the contourlines for some European countries, but the changes are minimal...
There have been quite a few changes to mkgmap, so some multipolygon errors in comparison to Mapnik are fixed too now. I too updated a bit the address search processing for Germany and fixe some more rather common access rules tagging mistakes. On the Velomap since 2 weeks, the routing on primaries and secondaries is a little bit degraded again, but the changes are rather small.
So that's been it, happy mapping and biking to everyone, I envy you but hope to be back in the outdoors ASAP!


text:
By Pure Matters
Detailed information on pregnancy and childbirth, including information on birth statistics, pregnancy planning, preconception care, prenatal care, pregnancy discomforts, pregnancy tests, pregnancy risks, pregnancy warning signs, labor and delivery.
A pregnancy is divided into three phases, called trimesters. Each trimester has its own significant milestones. The first trimester is the most fragile period, during which all major organs and systems are formed. Most birth defects and miscarriages occur during the first trimester. During the second and third trimester, the fetus is fully formed and grows and matures rapidly. The trimesters are divided as follows:
- first trimester: 0 - 12 weeks
- second trimester: 12 - 24 weeks
- third trimester: 24 - 40 weeks
(However, some authorities use the 42 weeks method divided by 3 trimesters with the 1st trimester, 0 - 13 weeks; the 2nd trimester, 14 - 28 weeks; and the 3rd trimester, 29 - 42 weeks.)
Listed in the directory below, you will find additional information regarding the three phases of pregnancy, for which we have provided a brief overview.
The First Trimester (0 - 12 Weeks)
The Second Trimester (12 - 24 Weeks)
The Third Trimester (24 - 40 Weeks)
Overview of Multiple Pregnancy
Symptoms and Diagnosis of Multiple Pregnancy
Complications of Multiple Pregnancy
Care and Management of Multiple Pregnancy
Source: http://resources.purematters.com/healthy-body/healthy-pregnancy


text:
Sunday 2 February
The Lee Sessions is the umbrella term for all authentic, traditional Irish music sessions in Cork city.Supported by Cork City Council, this trad session trail runs all year round, and features world-class musicians and singers, in Cork's most iconic bars.These renowned sessions, which enhance Cork's reputation as THE traditional music capital, are an absolute must-see, for locals and visitors alike!
This weekly session takes place in one of Cork's most famous bars, An SpailpÃn Fánach, and features some wonderful musicians and singers!
(021) 427 7949


text:
On 1st of June, 2020, Quadpack started operating in Japan, with the opening of a commercial office. With a strong presence in the Asia Pacific region, with facilities in Australia, China mainland, Hong Kong, Taiwan and Korea, Quadpack lands in Japan with high expectations about one of the most promising markets for the beauty packaging industry.
Quadpack has entered a strategic partnership with Italian company Premi. Premi specialises in customised glass and plastic primary packaging for the beauty industry. Under the terms of the agreement, Quadpack will support Premi's European expansion plans, while Premi will help extend Quadpack's stronghold in Italy.
Quadpack CEO Tim Eaves explains the logic behind the partnership: "Our global network offers Premi an established infrastructure into Europe. In turn, Premi will help us break into the fragrance market, while bringing some exciting new additions to our skin care product portfolio."
Premi's bespoke service and innovative technology and design have placed the company in a leadership position in the Italian cosmetics packaging market. With an in-house logistics department, over 200 proprietary moulds and a number of exclusive distribution agreements in place, Premi is poised for growth beyond its domestic market.
Premi president Alesandro Prestini stresses the synergy between the two companies: "Premi and Quadpack have matching values. We operate on a basis of total transparency with our partners, as well as our customers, seeking to build relationships that last. This is an excellent foundation upon which to expand our operations. Together, we can go further, quicker. And, as we say in Italy, 'L'unione fa la forza', or 'United we're strong'."
Premi and Quadpack will continue to service their existing client bases as before. However, clients will now have access to the expertise and complete product ranges of both companies.
The two companies project a combined turnover in Italy of €20m in 2012.
See also
Quadpack advances in sustainable procurement
Quadpack has held an EcoVadis Silver Medal since 2018, which means the organisation complies with the highest standards of CSR, covering environment, labour & human rights, ethics and sustainable procurement. By joining the Buyer Module, Quadpack will also be able to conduct the assessment and follow the evolution of all its suppliers, globally.
Starting a digital transformation journey
Technology has been at the heart of Quadpack's global expansion. In recent years, organic and inorganic growth posed many challenges for processes, data and system harmonisation throughout the business, so the organisation has opted for a bold digital transformation strategy that will support its future evolution: Quadpack Connect.
As Sustainability and Innovation are key priorities for Quadpack and the global consumer market, the organisation feels the responsibility to work with supply partners from all regions to establish a new way of doing business, where collaboration is the new competition. On November 13, 2019, Quadpack held a dedicated suppliers' conference on Sustainability and Innovation in Hong Kong to facilitate this new era of partnerships. Held during the 2019 edition of Cosmopack Asia, in attendance were Quadpack's top 20 Asia supply partners.
Quadpack Foundation gives back
The global reach of projects developed by the non-profit organisation proves that social action is in the heart of Quadpack's commitment with its surrounding communities. The non-profit organisation, established in 2016 went from Good to Great, ending the year with a record mark of 10 projects in 7 countries.
Every year, Independent Cosmetic Manufacturers and Distributors (ICMAD), a US-based organization of industry providers, organizes a prize to celebrate young design talent at college level. The ICMAD Young Designer of the Year Award, of which Quadpack is a proud sponsor, is part of our commitment with the future of beauty packaging.
Quadpack acquires Louvrette and is now placed among the top 10 cosmetic packaging providers in Europe
A recently announced deal has put Quadpack among the leaders in cosmetic packaging manufacturing in Europe. The German beauty packaging company, Louvrette, with more than 180 employees, 8,500m2 manufacturing facilities, 40 injection-moulding lines and a range of more than 100 innovative and sustainable products, is the new member of the Quadpack family.
What next for beauty? New trends unveiled at the Quadpack Roadshow
Twice a year, Quadpack managers, sales teams, designers, technicians and executives get together at the company's global HQ in Barcelona for the Roadshow. It's an exciting, inspiring event, where future trends in beauty packaging are presented. These predictions are based on solid market research, an intimate study of shifts in social and consumer behaviour, and most importantly, feedback from Quadpack's clients and customers.
Starting out right - The Quadpack Foundation and Los Primos
Quadpack Foundation, the charitable arm of Quadpack, is particularly concerned with helping disadvantaged children. As Accounting Manager at Quadpack's Dallas-based, US Distributor East Hill Industries, Casandra Sanders was well aware of Quadpack Foundation's values. She thought them a good fit with Los Primos Dallas, a local, non-profit organization she herself is involved with.
Quadpack opens new corporate floor in Barcelona
The last 2 years have seen hard work and growth for Quadpack - while the company experienced constant expansion, the teams have gotten bigger, requesting more space and comfort. The group commitment with sustainable practices and people wellbeing posed a very welcome challenge to the Facilities team in the Barcelona headquarters: how to create an office that is easily adaptable to the business changes, eco-conscious and welcoming to Quadpackers and visitors?
Quadpack boosts its Asian presence with a new office and service team in South Korea
South Korea is a global leader in the beauty industry. Not only does it host some of the world's largest cosmetic companies, but many trends born here have a huge influence in Europe, the US and beyond. Quadpack was an early adopter of the Korean beauty phenomenon. Since 2007, the company has been the exclusive partner of Yonwoo – pioneers of airless packaging – in Europe and Australia.
Translating Sustainable Development Goals into actions
The United Nations Global Compact initiative proposes 17 Sustainable Development Goals (SDGs) that lay out a path to end extreme poverty, fight inequality and injustice and protect our planet. Quadpack has now designated the four SDGs where, as a beauty packaging provider, it can have the greatest impact.
Held in Bologna, Italy every year, Cosmoprof Worldwide is one of the beauty industry's leading trade events, covering everything from raw materials to finished products. As Quadpack grows, logically so must its presence at trade fairs, and the intent at Cosmoprof 2019 was to make the company stand bigger, better and more Wow. It worked! This year, the Quadpack stand received a record number of visitors.
Seeking synergies at the Quadpack European Suppliers' Conference
Quadpack hosted its annual European Suppliers Conference in March 2019, an event that provided an opportunity for suppliers and partners to get together, learn, workshop common goals and study ways to grow together. Over 60 representatives attended the event at the historic 1898 Hotel in Barcelona.
Quadpack: a Little Big Company
Quadpack is a company built on people. Our skills, values, work ethic and shared vision are what drives us forward. We are today an almost 400-strong global team, expanding into new territories. Last year, we significantly increased our presence in Asia and the US. We invested €2.4 million in our production facilities. And we increased our sales by 15%, with a turnover set to hit €104 million.
Driving the debate on sustainability
Sustainability. Everyone is taking about it, but what does it really mean? There are many different interpretations and even more courses of action. So how can businesses best embrace it? As an active member of the beauty packaging industry, Quadpack has taken the debate to its clients, with a view to sharing knowledge and working together towards a common vision.
Nurturing tomorrow's talent in design and innovation
Quadpack is a company that depends on constant innovation, so encouraging and promoting talent is vital to what it does. Tied closely to its CSR (Corporate Social Responsibility) strategy, it works in several areas: strengthening ties between universities and industry, sponsoring relevant prizes and awards, boosting entrepreneurship and supporting small business initiatives.
Quadpack Foundation reaches out across the globe
2018 has been a busy year for Quadpack Foundation. Quadpack's charitable arm supports social and environmental projects wherever the company is present in the world, with an emphasis on helping disadvantaged children and young people get a good start in life. Throughout the year, it worked with NGOs in Europe, the US and Asia.
Cosmopack Asia: a time for partnership and celebration
Cosmopack Asia was a huge success for Quadpack this year. The YouWood collection in particular was a real crowd-puller, comprising selected Q-Line packs adorned with sustainably-sourced wood. As always, Yonwoo's airless packs proved very popular. Quadpack also participated in the event's SKINTONIC skincare project, plus we hosted our annual cocktail party – this year, in celebration of our 15th anniversary!
Innovation first: cutting-edge 3D printing technology accelerates creative process
Quadpack's department of Design and Advanced Technologies has invested over €200k in the latest 3D printing technology at its UK research & design facility. The Stratasys J750 will accelerate the early stages of bespoke package design and development, while helping to test new ideas.
Quadpack sponsors degree project at ELISAVA design school
The way we experience fragrance is changing. Young consumers have different expectations and want more than a nice scent in an attractive bottle. So how do we relate to fragrance and how can packagers ensure engagement with the new generation? Investigating this topic was Quadpack's brief to the students at the ELISAVA University School of Design and Engineering in Barcelona, Spain.
Quadpack Industries closes 2017 with €90.7m turnover and 29% growth
Quadpack Industries delivered strong results in 2017, thanks to its diversified business model and sustainable growth strategy. EBITDA reached a healthy €6.8 million, an increase of 2% over the 2016 results. With a consolidated presence in the European skincare packaging market, 2017 saw the company increase its penetration of the fragrance and make-up markets, together now accounting for 35% of its business. Its hybrid manufacturing/sourcing model keeps its offering flexible, while delivering specialised differentiation through its own manufacturing output.
Quadpack hosts inaugural Asia Supplier Conference
Quadpack held its Asia Supplier Conference on 8 May 2018 in Kowloon, Hong Kong, in recognition of the strategic importance of its Asian business partnerships. Held at the stylish Hotel ICON, over 30 key suppliers attended the event, as did Quadpack's Asia Pacific team.
Manufacturing Division expansion reflects corporate growth
A new production line has been installed at the Quadpack Plastics injection-moulding plant to manage the increased volume of acrylic jar manufacture. Quadpack's Manufacturing Division now has a combined production capacity of 170 million items a year, including the Quadpack Wood and Quadpack Impressions facilities.
Roll up, roll up! The most inclusive show's in town!
There is no surer way of putting a smile on a child's face than a circus performance. When that child is disadvantaged through health or circumstance, it's a way of forgetting day-to-day struggles for some much-needed fun. So when Circus Starr announced its plans to go to Stoke-on-Trent, Quadpack Foundation saw the perfect opportunity to lend a helping hand.
Quadpack ramps up US activity with new appointment, new distributor
Quadpack has made two key moves designed to increase its penetration into the US market. The company has appointed Anthony Le Minoux as head of its US operations. At the same time, it has named East Hill Industries as the official distributor of its Q-Line range of products in the United States.
- Gratiela Adriana Stefan
- Company News -> QP Corporate News
- English
- Created 17 May 2012
- Modified 23 Jul 2018
- Hits 1831